The newsroom
Research & news
Follow the research, the regulatory record and the people building the peptide industry. Each entry identifies whether you are reading onsite coverage or a link to an outside source.
2 publications
Research· Source synthesis
BPC-157 vs TB-500: Inside the Rat Tendon Study and Its Limits
A closer look at the measurements, earlier tendon research and the questions a small animal experiment can answer.
Temporary integration QA
Regulatory· Source link
Jesse Dresser Featured in Forbes: “Peptides May Soon Be Legal. These Companies Are Ready To Cash In”
The FDAs review of seven peptides has sparked significant interest across the healthcare industry, with compounding pharmacies, telehealth companies, investors, and other market participants preparing for the possibility of expanded legal access to peptide compounding. As federal regulators conside…
Frier Levitt